(Q39775243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Suberoylanilide hydroxamic acid (SAHA) at subtoxic concentrations increases the adhesivity of human leukemic cells to fibronectin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Zbyněk Hrkal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Katerina Kuzelová

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Michaela Pluskalová

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Petra Otevrelová

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Klára Elknerová

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Dana Grebenová

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cellular Biochemistry

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

184-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19911379%20AND%20SRC:MED&resulttype=core&format=json

ADP-ribosylation of Rho enhances adhesion of U937 cells to fibronectin via the alpha 5 beta 1 integrin receptor

12 February 2020

cites work

1 reference

Lim kinases, regulators of actin dynamics

21 January 2018

1 reference

Variations in c-Myc and p21WAF1 expression protect normal peripheral blood lymphocytes against BimEL-mediated cell death.

21 January 2018

1 reference

Purified integrin adhesion complexes exhibit actin-polymerization activity

21 January 2018

1 reference

Linkage of caspase-mediated degradation of paxillin to apoptosis in Ba/F3 murine pro-B lymphocytes

21 January 2018

1 reference

Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma

21 January 2018

1 reference

Histone deacetylase inhibitors: overview and perspectives

21 January 2018

1 reference

Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma

21 January 2018

1 reference

Beta3 tyrosine phosphorylation and alphavbeta3-mediated adhesion are required for Vav1 association and Rho activation in leukocytes

21 January 2018

1 reference

Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?

21 January 2018

1 reference

Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells.

21 January 2018

1 reference

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

21 January 2018

1 reference

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

21 January 2018

1 reference

Functional proteomics identifies protein-tyrosine phosphatase 1B as a target of RhoA signaling

21 January 2018

1 reference

Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells

21 January 2018

1 reference

Labeling of apoptotic JURL-MK1 cells by fluorescent caspase-3 inhibitor FAM-DEVD-fmk occurs mainly at site(s) different from caspase-3 active site

21 January 2018

1 reference

Caspase activation during phorbol ester-induced apoptosis requires ROCK-dependent myosin-mediated contraction

21 January 2018

1 reference

Regulation of RhoA-dependent ROCKII activation by Shp2

21 January 2018

1 reference

Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma

21 January 2018

1 reference

Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells

21 January 2018

1 reference

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

21 January 2018

1 reference

The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance

21 January 2018

1 reference

Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications

21 January 2018

1 reference

A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

Histone deacetylase inhibitors

21 January 2018

1 reference

Roles of Necl-5/poliovirus receptor and Rho-associated kinase (ROCK) in the regulation of transformation of integrin alpha(V)beta(3)-based focal complexes into focal adhesions.

21 January 2018

1 reference

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

21 January 2018

1 reference

Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors

21 January 2018

1 reference

21 January 2018

1 reference

Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma

21 January 2018

1 reference

Review: Biological relevance of disseminated tumor cells in cancer patients

21 January 2018

1 reference

Histone deacetylase inhibitors in clinical development

21 January 2018

1 reference

Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells

21 January 2018

1 reference

Apoptotic and autophagic cell death induced by histone deacetylase inhibitors

21 January 2018

1 reference

Rho kinase in the regulation of cell death and survival

21 January 2018

1 reference

Apoptosis: controlled demolition at the cellular level

21 January 2018

1 reference

Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid

21 January 2018

1 reference

Rho GTPases and cell cycle control

21 January 2018

1 reference

Histone deacetylase inhibitors: molecular mechanisms of action

21 January 2018

1 reference